Close
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO Jun 1, 2024 08:25PM

BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib (JAB-21822) in combination with a SHP2 inhibitor (JAB-3312) in frontline non-small cell lung cancer (NSCLC) patients harboring KRAS G12C mutation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting as form of oral presentation. Jacobio... (continue reading...)


OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions League Final 2024 Jun 1, 2024 08:24PM

London, United Kingdom--(Newsfile Corp. - June 1, 2024) - The UEFA Champions League final kicked off today at London's legendary Wembley Stadium. As the Official Global Partner of the top-flight football competition, OPPO brought its flagship smartphone, OPPO Find X7 Ultra, to capture unforgettable moments from the match and celebrate the crowning of the 2024 UEFA Champions League winners. The OPPO Find X7 Ultra is the latest flagship phone to... (continue reading...)


OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaká at the UEFA Champions League Final 2024 Jun 1, 2024 08:15PM LONDON, UNITED KINGDOM - Media OutReach Newswire – 1 June 2024 - The UEFA Champions League final kicked off today at London's legendary Wembley Stadium. As the Official Global Partner of the top-flight football competition, OPPO brought its flagship smartphone, OPPO Find X7 Ultra, to capture unforgettable moments from the match and celebrate the crowning of the 2024 UEFA Champions League winners. The OPPO Find X7 Ultra is the latest flagship phone to feature... (continue reading...)
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC Jun 1, 2024 08:17PM
  • EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab in combination with chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).
  • Sugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC,... (continue reading...)

Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever Jun 1, 2024 08:15PM

Heineken® says cheers to the Real Hardcore Fans as thousands of fans faces adorn the celebration confetti during the UEFA Champions League Final 2024 Trophy Lift at Wembley

LONDON, June 01, 2024 (GLOBE NEWSWIRE) -- Tonight, Heineken® has created a way for thousands of ‘real hardcore fans’ to take part in the UEFA Champions League Final Trophy celebration, marking the culmination of the ‘Cheers To The Real Hardcore Fans’ 2024 campaign.

Following... (continue reading...)


More Press Releases

View Older Stories

Jun 1, 2024 08:00PM Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
Jun 1, 2024 08:00PM Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00PM Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
Jun 1, 2024 07:13PM GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
May 31, 2024 07:35PM Quebec Precious Metals Announces First Closing of a Private Placement
Jun 1, 2024 06:09PM LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Jun 1, 2024 05:52PM Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
Jun 1, 2024 05:10PM National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
Jun 1, 2024 04:30PM Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
Jun 1, 2024 03:40PM BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
Jun 1, 2024 03:00PM Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Jun 1, 2024 03:00PM First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
Jun 1, 2024 02:40PM Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy
Jun 1, 2024 02:30PM Sun, Sand, and Smooth Skin: Grab Ulike Air 10 for a Summer Beach Adventure
Jun 1, 2024 02:25PM New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
Jun 1, 2024 02:20PM Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
Jun 1, 2024 01:45PM Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
Jun 1, 2024 01:42PM Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
Jun 1, 2024 01:20PM All-in-One Job Shop Software for Fabrication Shops by Steelhead Technologies
Jun 1, 2024 12:43PM Sustainable Tourism Initiative: Responsible Travel Merchandise Store Announced
Jun 1, 2024 02:20PM What Custom Stickers Are Best for Glass?
Jun 1, 2024 02:20PM Robotbulls - The Future of Cryptocurrency Trading: Integrating AI and Blockchain Data
Jun 1, 2024 01:10PM Taseko Announces that Operations at its Gibraltar Mine have been Suspended
Jun 1, 2024 12:59PM Michael Bernstein Offers Dropshipping Consulting to Help Clients Build Successful, Long-Term Businesses
Jun 1, 2024 01:02PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
Jun 1, 2024 01:01PM PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
Jun 1, 2024 12:55PM Union members and allies mark Injured Workers’ Day in locations across Ontario
Jun 1, 2024 12:30PM FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure
Jun 1, 2024 12:36PM Prospera Energy Inc. Announces 2023 Financial Results
Jun 1, 2024 11:40AM Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
Jun 1, 2024 11:00AM WATCH by Aisles: A Revolutionary AI System for Public Safety
Jun 1, 2024 11:56AM CIO Women Magazine Spotlights Claudia Patricia Eusse, CEO, The Eusse Group, as Influential Women Leaders in Real Estate
Jun 1, 2024 11:56AM Mr. Business Magazine Spotlights Diana Muniz-Lebrun, Founding Partner and CEO at Olympus Marketing
Jun 1, 2024 11:00AM ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
Jun 1, 2024 10:00AM Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
Jun 1, 2024 10:00AM First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
Jun 1, 2024 10:00AM "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
Jun 1, 2024 10:33AM Gregory P Lee Personal Injury Lawyer The Woodlands Expands Services to Meet Rising Demand in Texas for Personal Injury Cases
Jun 1, 2024 10:30AM Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024
Jun 1, 2024 10:28AM Revolutionizing Sustainability: The Environment Protection Technologies Expo
Jun 1, 2024 09:30AM Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
Jun 1, 2024 09:15AM Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
Jun 1, 2024 09:00AM Fungies Mushroom Gummies Announces Major Retail Expansion and Availability at Walmart
Jun 1, 2024 09:00AM Vincent Todd Announces the Introduction of Todd Agriscience
Jun 1, 2024 09:00AM Hyundai Motor America Reports May 2024 Sales
Jun 1, 2024 09:00AM Beverly Hills MD Celebrates Its 10th Anniversary
View Older Stories